Akermin hires new Chief Technology Officer
Chicago, IL - Treva Partners joins Akermin, a leading developer of biocatalysis technology, in welcoming Dr. Alex Zaks as its new Chief Technology Officer. Reporting to the CEO, Alex will oversee Akermin's research and development organization as well as determine the overall technical strategy for the company. Treva Partners worked closely with Akermin's CEO and Board on this critical search assignment.
Prior to joining Akermin, Alex was an executive with Schering-Plough/Merck, responsible for managing its technology organizations and instrumental in the development of several new pharmaceuticals. Alex started his career with Enzytech after completing his Ph.D. studies at MIT. Born and raised in Russia, Alex brings depth and perspective to Akermin's technology development needs, including the sensitivity necessary to succeed when working within and across diverse areas.
About Treva Partners
Treva Partners is a leading, retained executive search firm known for delivering consistent, high-value results. Focused on addressing key leadership needs in the Life Science and Industrial markets, we have completed numerous search assignments spanning multiple levels of leadership, from Presidents and VP/GMs to C-Suite Executives and Board members. Treva Partners provides high value solutions and strategic counsel to a wealth of organizations, addressing each client's human capital needs with passion and intelligence. We are leaders in retained executive search thanks to our high performance culture and to the industry knowledge and insight we have developed over decades serving clients dedicated to growth. As experts in the Life Science and Industrial markets, we enable better decision making, helping our clients excel in both talent acquisition and management.